The stress-activated protein kinase pathways

Cellular and Molecular Life Sciences

Volumn 55, Issue 10, 1999, Pages 1230-1254

  Tibbles, L A ^a,b   Woodgett, J R ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Apoptosis; Jun N terminal kinase (JNK); Mitogen activated protein kinase (MAPK); p38; Stress activated protein kinase (SAPK)

Indexed keywords

ADAPTOR PROTEIN; ANISOMYCIN; CISPLATIN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GROWTH FACTOR; GUANOSINE TRIPHOSPHATASE; MEMBRANE RECEPTOR; MESYLIC ACID METHYL ESTER; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; MITOMYCIN C; PACLITAXEL; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; RAPAMYCIN; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TENIPOSIDE; TRANSCRIPTION FACTOR; VINBLASTINE;

ADAPTATION; APOPTOSIS; CELL DIFFERENTIATION; CELL GROWTH; CELL MEMBRANE; CELL NUCLEUS; CELL TRANSFORMATION; ENZYME ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; IMMUNOSTIMULATION; INFLAMMATION; MITOSIS; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, CHEMICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASES; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 0033567291     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050369     Document Type: Review

References (373)

1. 1 Kyriakis J. M., Banerjee P., Nikolakaki E., Dai T., Rubie E. A., Ahmad M. F. et al. (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156-160
2. 2 Derijard B., Hibi M., Wu I. H., Barrett T., Su B., Deng T. et al. (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037
3. 3 Kallunki T., Su B., Tsigelny I., Sluss H. K., Derijard B., Moore G. et al. (1994) JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8: 2996-3007
4. 4 Casanova E., Garate C., Ovalle S., Calvo P. and Chinchetru M. A. (1996) Identification of four splice variants of the mouse stress-activated protein kinase JNK/SAPK alpha-isoform. Neuroreport 7: 1320-1324
5. 5 Gupta S., Barrett T., Whitmarsh A. J., Cavanagh J., Sluss H. K., Derijard B. et al. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15: 2760-2770
6. 6 Dai T., Rubie E., Franklin C. C., Kraft A., Gillespie D. A., Avruch J. et al. (1995) Stress-activated protein kinases bind directly to the delta domain of c-Jun in resting cells: implications for repression of c-Jun function. Oncogene 10: 849-855
7. 7 Kallunki T., Deng T., Hibi M. and Karin M. (1996) c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87: 929-939
8. 8 Whitmarsh A. J., Shore P., Sharrocks A. D. and Davis R. J. (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science 269: 403-407
9. 9 Zinck R., Cahill M. A., Kracht M., Sachsenmaier C., Hipskind R. A. and Nordheim A. (1995) Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol. Cell Biol. 15: 4930-4938
10. 10 Gille H., Strahl T. and Shaw P. E. (1995) Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 5: 1191-2000
11. 11 Cavigelli M., Dolfi F., Claret F. X. and Karin M. (1995) Induction of c-fos expression through JNK-mediated TCF/ Elk-1 phosphorylation. EMBO J. 14: 5957-5964
12. 12 Price M. A., Cruzalegui F. H. and Treisman R. (1996) The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c-fos transcription in response to UV light. EMBO J. 15: 6552-6563
13. 13 Whitmarsh A. J., Yang S. H., Su M. S., Sharrocks A. D. and Davis R. J. (1997) Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell Biol. 17: 2360-2371
14. 14 Yang S. H., Whitmarsh A. J., Davis R. J. and Sharrocks A. D. (1998) Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J. 17: 1740-1749
15. 15 Janknecht R. and Hunter T. (1997) Activation of the Sap-1a transcription factor by the c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase. J. Biol. Chem. 272: 4219-4224
16. 16 Zhang Y., Feng X. H. and Derynck R. (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394: 909-913
17. 17 van Dam H., Wilhelm D., Herr I., Steffen A., Herrlich P. and Angel P. (1995) ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14: 1798-1811
18. 18 O'Hagan R. C., Tozer R. G., Symons M., McCormick F. and Hassell J. A. (1996) The activity of the Els transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene 13: 1323-1333
19. 19 Chow C. W., Rincon M., Cavanagh J., Dickens M. and Davis R. J. (1997) Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 278: 1638-1641
20. 20 Martinez-Martinez S., Gomez del Arco P., Armesilla A. L., Aramburu J., Luo C., Rao A. et al. (1997) Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells. Mol. Cell Biol. 17: 6437-6447
21. 21 Ming X.-F., Kaiser M. and Moroni C. (1998) c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. EMBO J. 17: 6039-6048
22. 22 Han J., Lee J. D., Bibbs L. and Ulevitch R. J. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811
23. 23 Enslen H., Raingeaud J. and Davis R. J. (1998) Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273: 1741-1748
24. 24 Li Z., Jiang Y., Ulevitch R. J. and Han J. (1996) The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem. Biophys. Res. Commun. 228: 334-340
25. 25 Cuenda A., Cohen P., Buec-Scherrer V. and Goedert M. (1997) Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16: 295-305
26. 26 Goedert M., Cuenda A., Craxton M., Jakes R. and Cohen P. (1997) Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J. 16: 3563-3571
27. 27 Mendelson K. G., Contois L. R., Tevosian S. G., Davis R. J. and Paulson K. E. (1996) Independent regulation of JNK, p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc. Natl. Acad. Sci. USA 93: 12908-12913
28. 28 Jiang Y., Chen C., Li Z., Guo W., Gegner J. A., Lin S. et al. (1996) Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J. Biol. Chem. 271: 17920-17926
29. 29 Janknecht R. and Hunter T. (1997) Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J. 16: 1620-1627
30. 30 Wang X. Z. and Ron D. (1996) Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 272: 1347-1349
31. 31 Hazzalin C. A., Cano E., Cuenda A., Barratt M. J., Cohen P. and Mahadevan L. C. (1996) p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ ATF-2 phosphorylation are insufficient. Curr. Biol. 6: 1028-1031
32. 32 Clifton A. D., Young P. R. and Cohen P. (1996) A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress. FEBS Lett. 392: 209-214
33. 33 Ni H., Wang X. S., Diener K. and Yao Z. (1998) MAP-KAPK5, a novel mitogen-activated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellular-regulated kinase (ERK) and p38 kinase. Biochem. Biophys. Res. Commun. 243: 492-496
34. 34 Fukunaga R. and Hunter T. (1997) MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16: 1921-1933
35. 35 Guay J., Lambert H., Gingras-Breton G., Lavoie J. N., Huot J. and Landry J. (1997) Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J. Cell. Sci. 110: 357-368
36. 36 Lee J. C., Laydon J. T., McDonnell P. C., Gallagher T. F., Kumar S., Green D. et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746
37. 37 Hazzalin C. A., Cuenda A., Cano E., Cohen P. and Mahadevan L. C. (1997) Effects of the inhibition of p38/RK MAP kinase on induction of five fos and jun genes by diverse stimuli. Oncogene 15: 2321-2331
38. 38 White R. A., Hughes R. T., Adkison L. R., Bruns G. and Zon L. I. (1996) The gene encoding protein kinase SEK1 maps to mouse chromosome II and human chromosome 17. Genomics 34: 430-432
39. 39 Sanchez I., Hughes R. T., Mayer B. J., Yee K., Woodgett J. R., Avruch J. et al. (1994) Role of SAPK, ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372: 794-798
40. 40 Moriguchi T., Kawasaki H., Matsuda S., Gotoh Y. and Nishida E. (1995) Evidence for multiple activators for stress-activated protein kinase/c-Jun amino-terminal kinases. Existence of novel activators. J. Biol. Chem. 270: 12969-12972
41. 41 Zanke B. W., Rubie C. A., Winnett E., Chan J., Randall S., Parsons M. et al. (1996) Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes. J. Biol. Chem. 271: 29876-29881
42. 42 Meier R., Rouse J., Cuenda A., Nebreda A. R. and Cohen P. (1996) Cellular stresses and cytokines activate multiple mitogen-activated protein kinase kinase homologues in PC12 and KB cells. Eur. J. Biochem. 236: 796-805
43. 43 Nishina H., Fischer K. D., Radvanyi L., Shahinian A., Hakem R., Rubie E. A. et al. (1997) Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385: 350-353
44. 44 Yang D., Tournier C., Wysk M., Lu H. T., Xu J., Davis R. J. et al. (1997) Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. USA 94: 3004-3009
45. 45 Ganiatsas S., Kwee L., Fujiwara Y., Perkins A., Ikeda T., Labow M. A. et al. (1998) SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc. Natl. Acad. Sci. USA 95: 6881-6886
46. 46 Tournier C., Whitmarsh A. J., Cavanagh J., Barrett T. and Davis R. J. (1997) Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. USA 94: 7337-7342
47. 47 Lawler S., Cuenda A., Goedert M. and Cohen P. (1997) SKK4, a novel activator of stress-activated protein kinase-1 (SAPK1/JNK). FEBS Lett. 414: 153-158
48. 48 Lu X., Nemoto S. and Lin A. (1997) Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38. J. Biol. Chem. 272: 24751-24754
49. 49 Holland P. M., Suzanne M., Campbell J. S., Noselli S. and Cooper J. A. (1997) MKK7 is A stress-activated mitogen-activated protein kinase kinase functionally related to hemipterous. J. Biol. Chem. 272: 24994-24998
50. 50 Moriguchi T., Toyoshima F., Masuyama N., Hanafusa H., Gotoh Y. and Nishida E. (1997) A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses. EMBO J. 16: 7045-7053
51. 51 Yao Z., Diener K., Wang X. S., Zukowski M., Matsumoto G., Zhou G. et al. (1997) Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPKs/ JNKs) by a novel mitogen-activated protein kinase kinase. J. Biol. Chem. 272: 32378-32383
52. 52 Wu Z., Wu J., Jacinto E. and Karin M. (1997) Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase. Mol. Cell Biol. 17: 7407-7416
53. 53 Foltz I. N., Gerl R. E., Wieler J. S., Luckach M., Salmon R. A. and Schrader J. W. (1998) Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/ SAPK) activated by environmental stresses and physiological stimuli. J. Biol. Chem. 273: 9344-9351
54. 54 Yang J., New L., Jiang Y., Han J. and Su B. (1998) Molecular cloning and characterization of a human protein kinase that specifically activates c-Jun N-terminal kinase. Gene 212: 95-102
55. 55 Stein B., Brady H., Yang M. X., Young D. B. and Barbosa M. S. (1996) Cloning and characterization of MEK6, a novel member or the mitogen-activated protein kinase kinase cascade. J. Biol. Chem. 271: 11427-11433
56. 56 Cuenda A., Alonso G., Morrice N., Jones M., Meier R., Cohen P. et al. (1996) Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress-and cytokine-stimulated monocytes and epithelial cells. EMBO J. 15: 4156-4164
57. 57 Yan M., Dai T., Deak J. C., Kyriakis J. M., Zon L. I., Woodgett J. R. et al. (1994) Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372: 798-800
58. 58 Cuenda A. and Dorow D. S. (1998) Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1. Biochem. J. 333: 11-15
59. 59 Cardone M. H., Salvesen G. S., Widmann C., Johnson G. and Frisch S. M. (1997) The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 90: 315-323
60. 60 Widmann C., Johnson N. L., Gardner A. M., Smith R. J. and Johnson G. L. (1997) Potentiation of apoptosis by low close stress Stimuli in cells expressing activated MEK kinase 1. Oncogene 15: 2439-2447
61. 61 Deak J. C., Cross J. V., Lewis M., Qian Y., Parrott L. A., Distelhorst C. W. et al. (1998) Fas-induced proteolytic activation and intracellular redistribution of the stress-signaling kinase MEKK1. Proc. Natl. Acad. Sci. USA 95: 5595-5600
62. 62 Deak J. C. and Templeton D. J. (1997) Regulation of the activity of MEK kinase 1 (MEKK1) by autophosphorylation within the kinase activation domain. Biochem. J. 322: 185-192
63. 63 Blank J. L., Gerwins P., Elliott E. M., Sather S. and Johnson G. L. (1996) Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase. J. Biol. Chem. 271: 5361-5368
64. 64 Ellinger-Ziegelbauer H., Brown K., Kelly K. and Siebenlist U. (1997) Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein kinase/ERK kinase kinase 3 (MEKK) derivative. J. Biol. Chem. 272: 2668-2674
65. 65 Gerwins P., Blank J. L. and Johnson G. L. (1997) Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway. J. Biol. Chem. 272: 8288-8295
66. 66 Deacon K. and Blank J. L. (1997) Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo. J. Biol. Chem. 272: 14489-14496
67. 67 Fanger G. R., Johnson N. L. and Johnson G. L. (1997) MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J. 16: 4961-4972
68. 68 Rana A., Gallo K., Godowski P., Hirai S., Ohno S., Zon L. et al. (1996) The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1. J. Biol. Chem. 271: 19025-19028
69. 69 Tibbles L. A., Ing Y. L., Kiefer F., Chan J., Iscove N., Woodgett J. R. et al. (1996) MLK-3 activates the SAPK/ JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J. 15: 7026-7035
70. 70 Hirai S., Katoh M., Terada M., Kyriakis J. M., Zon L. I., Rana A. et al. (1997) MST/MLK2, a member of the mixed lineage kinase family, directly phosphorylates and activates SEK1, an activator of c-Jun N-terminal kinase/stress-activated protein kinase. J. Biol. Chem. 272: 15167-15173
71. 71 Hirai S., Noda K., Moriguchi T., Nishida E., Yamashita A., Deyama T. et al. (1998) Differential activation of two JNK activators, MKK7 and SEK1, by MKN28-derived nonreceptor serine/threonine kinase/mixed lineage kinase 2. J. Biol. Chem. 273: 7406-7412
72. 72 Hirai S., Izawa M., Osada S., Spyrou G. and Ohno S. (1996) Activation of the JNK pathway by distantly related protein kinases, MEKK and MUK. Oncogene 12: 641-650
73. 73 Fan G., Merritt S. E., Kortenjann M., Shaw P. E. and Holzman L. B. (1996) Dual leucine zipper-bearing kinase (DLK) activates p46SAPK and p38mapk but not ERK2. J. Biol. Chem. 271: 24788-24793
74. 74 Sakuma H., Ikeda A., Oka S., Kozutsumi Y., Zanetta J. P. and Kawasaki T. (1997) Molecular cloning and functional expression of a cDNA encoding a new member of mixed lineage protein kinase from human brain. J. Biol. Chem. 272: 28622-28629
75. 75 Takekawa M., Posas F. and Saito H. (1997) A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways. EMBO J. 16: 4973-4982
76. 76 Nagata K., Puls A., Futter C., Aspenstrom P., Schaefer E., Nakata T. et al. (1998) The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3. EMBO J. 17: 149-158
77. 77 Salmeron A., Ahmad T. B., Carlile G. W., Pappin D., Narsimhan R. P. and Ley S. C. (1996) Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15: 817-826
78. 78 Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T. et al. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94
79. 79 Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N. et al. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270: 2008-2011
80. 80 Moriguchi T., Kuroyanagi N., Yamaguchi K., Gotoh Y., Irie K., Kano T. et al. (1996) A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem. 271: 13675-13679
81. 81 Ceci J. D., Patriotis C. P., Tsatsanis C., Makris A. M., Kovatch R., Swing D.A. et al. (1997) Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev. 11: 688-700
82. 82 Shirakabe K., Yamaguchi K., Shibuya H., Irie K., Matsuda S., Moriguchi T. et al. (1997) TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem. 272: 8141-8144
83. 83 Pombo C. M., Kehrl J. H., Sanchez I., Katz P., Avruch J., Zon L. I. et al. (1995) Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase. Nature 377: 750-754
84. 84 Kiefer F., Tibbles L. A., Anafi M., Janssen A., Zanke B. W., Lassam N. et al. (1996) HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway. EMBO J. 15: 7013-7025
85. 85 Anafi M., Kiefer F., Gish G. D., Mbamalu G., Iscove N. N. and Pawson T. (1997) SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1. J. Biol. Chem. 272: 27804-27811
86. 86 Su Y. C., Han J., Xu S., Cobb M. and Skolnik E. Y. (1997) NIK is a new Ste20-related kinase that binds NCR and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain. EMBO J. 16: 1279-1290
87. 87 Tung R. M. and Blenis J. (1997) A novel human SPS1/ STE20 homologue, KHS, activates Jun N-terminal kinase. Oncogene 14: 653-659
88. 88 Diener K., Wang X. S., Chen C., Meyer C. F., Keesler G., Zukowski M. et al. (1997) Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase. Proc. Natl. Acad. Sci. USA 94: 9687-9692
89. 89 Shi C. S. and Kehrl J. H. (1997) Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-kappaB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway. J. Biol. Chem. 272: 32102-32107
90. 90 Graves J. D., Gotoh Y., Draves K. E., Ambrose D., Han D. K., Wright M. et al. (1998) Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J. 17: 2224-2234
91. 91 Polverino A., Frost J., Yang P., Hutchison M., Neiman A. M., Cobb M. H. et al. (1995) Activation of mitogen-activated protein kinase cascades by p21-activated protein kinases in cell-free extracts of Xenopus oocytes. J. Biol. Chem. 270: 26067-26070
92. 92 Bagrodia S., Derijard B., Davis R. J. and Cerione R. A. (1995) Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 270: 27995-27998
93. 93 Brown J. L., Stowers L., Baer M., Trejo J., Coughlin S. and Chant J. (1996) Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. Curr. Biol. 6: 598-605
94. 94 Frost J. A., Xu S., Hutchison M. R., Marcus S. and Cobb M. H. (1996) Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members. Mol. Cell Biol. 16: 3707-3713
95. 95 Teramoto H., Crespo P., Coso O. A., Igishi T., Xu N. and Gutkind J. S. (1996) The small GTP-binding protein rho activates c-Jun N-terminal kinases/stress-activated protein kinases in human kidney 293T cells. Evidence for a Pak-independent signaling pathway. J. Biol. Chem. 271: 25731-25734
96. 96 Zhang S., Han J., Sells M. A., Chernoff J., Knaus U. G., Ulevitch R. J. et al. (1995) Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. Biol. Chem. 270: 23934-23936
97. 97 Whitmarsh A. J., Cavanagh J., Tournier C., Yasuda J. and Davis R. J. (1998) A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281: 1671-1674
98. 98 Coso O. A., Chiariello M., Yu J. C., Teramoto H., Crespo P., Xu N. et al. (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81: 1137-1146
99. 99 Minden A., Lin A., Claret F. X., Abo A. and Karin M. (1995) Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81: 1147-1157
100. 100 Olson M. F., Ashworth A. and Hall A. (1995) An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through GI. Science 269: 1270-1272
101. 101 Joneson T., McDonough M., Bar-Sagi D. and Van Aelst L. (1996) RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase. Science 274: 1374-1376
102. 102 Westwick J. K., Lambert Q. T., Clark G. J., Symons M., Van Aelst L., Pestell R. G. et al. (1997) Rac regulation of transformation, gene expression, and actin organization by multiple. PAK-independent pathways. Mol. Cell Biol. 17: 1324-1335
103. 103 Nagata K., Driessens M., Lamarche N., Gorski J. L. and Hall A. (1998) Activation of G1 progression, JNK mitogen-activated protein kinase, and actin filament assembly by the exchange factor FGD1. J. Biol. Chem. 273: 15453-15457
104. 104 Keely P. J., Westwick J. K., Whitehead I. P., Der C. J. and Parise L. V. (1997) Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390: 632-636
105. 105 Lamarche N., Tapon N., Stowers L., Burbelo P. D., Aspenstrom P., Bridges T. et al. (1996) Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell 87: 519-529
106. 106 Tapon N., Nagata K., Lamarche N. and Hall A. (1998) A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways. EMBO J. 17: 1395-1404
107. 107 Kawasaki H., Moriguchi T., Matsuda S., Li H. Z., Nakamura S., Shimohama S. et al. (1996) Ras-dependent and Ras-independent activation pathways for the stress-activated-protein-kinase cascade. Eur. J. Biochem. 241: 315-321
108. 108 Rausch O. and Marshall C. J. (1997) Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol. Cell Biol. 17: 1170-1179
109. 109 Terada K., Kaziro Y. and Satoh T. (1997) Ras-dependent activation of c-Jun N-terminal kinase/stress-activated protein kinase in response to interleukin-3 stimulation in hematopoietic BaF3 cells. J. Biol. Chem. 272: 4544-4548
110. 110 Tago K., Kaziro Y. and Satoh T. (1998) Functional involvement of mSos in interleukin-3 and thrombin stimulation of the Ras, mitogen-activated protein kinase pathway in BaF3 murine hematopoietic cells. J. Biochem. (Tokyo) 123: 659-667
111. 111 Crespo P., Bustelo X. R., Aaronson D. S., Coso O. A., Lopez-Barahona M., Barbacid M. et al. (1996) Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene 13: 455-460
112. 112 Olson M. F., Pasteris N. G., Gorski J. L. and Hall A. (1996) Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases. Curr. Biol. 6: 1628-1633
113. 113 Teramoto H., Salem P., Robbins K. C., Bustelo X. R. and Gutkind J. S. (1997) Tyrosine phosphorylation of the vav proto-oncogene product links FcepsilonRI to the Rac1-JNK pathway. J. Biol. Chem. 272: 10751-10755
114. 114 O'Rourke L. M., Tooze R., Turner M., Sandoval D. M., Carter R. H., Tybulewicz V. L. et al. (1998) CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 8: 635-645
115. 115 Wang D. S., Deng T. and Shaw G. (1997) Membrane binding and enzymatic activation of a Dbl homology domain require the neighboring pleckstrin homology domain. Biochem. Biophys. Res. Commun. 234: 183-189
116. 116 Tanaka S., Ouchi T. and Hanafusa H. (1997) Downstream of Crk adaptor signaling pathway: activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G. Proc. Natl. Acad. Sci. USA 94: 2356-2361
117. 117 Tanaka S. and Hanafusa H. (1998) Guanine-nucleotide exchange protein C3G activates JNK1 by a ras-independent mechanism. JNK1 activation inhibited by kinase negative forms of MLK3 and DLK mixed lineage kinases. J. Biol. Chem. 273: 1281-1384
118. 118 Michiels F., Stam J. C., Hordijk P. L., van der Kammen R. A., Ruuls-Van Stalle L., Feltkamp C. A. et al. (1997) Regulated membrane localization of Tiam1, mediated by the NH2-terminal pleckstrin homology domain, is required for Rac-dependent membrane ruffling and C-Jun NH2-terminal kinase activation. J. Cell. Biol. 137: 387-398
119. 119 Bellanger J. M., Lazaro J. B., Diriong S., Fernandez A., Lamb N. and Debant A. (1998) The two guanine nucleotide exchange factor domains of Trio link the Rac1 and the RhoA pathways in vivo. Oncogene 16: 147-152
120. 120 Alberts A. S. and Treisman R. (1998) Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1. EMBO J. 17: 4075-4085
121. 121 Liu Z. G., Hsu H., Goeddel D. V. and Karin M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87: 565-576
122. 122 Lee S. Y., Reichlin A., Santana A., Sokol K. A., Nussenzweig M. C. and Choi Y. (1997) TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 7: 703-713
123. 123 Min W. and Pober J. S. (1997) TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ ATF2 pathways. J. Immunol. 159: 3508-3518
124. 124 Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M. et al. (1998) ASK1 is essential for JNK/SAPK activation by TRAF2. Molecular Cell 2: 389-395
125. 125 Natoli G., Costanzo A., Ianni A., Templeton D. J., Woodgett J. R., Balsano C. et al. (1997) Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275: 200-203
126. 126 Reinhard C., Shamoon B., Shyamala V. and Williams L. T. (1997) Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J. 16: 1080-1092
127. 127 Song H. Y., Regnier C. H., Kirschning C. J., Goeddel D. V. and Rothe M. (1997) Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94: 9792-9796
128. 128 Natoli G., Costanzo A., Moretti F., Fulco M., Balsano C. and Levrero M. (1997) Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase. J. Biol. Chem. 272: 26079-26082
129. 129 Yang X., Khosravi-Far R., Chang H. Y. and Baltimore D. (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89: 1067-1076
130. 130 Chang H. Y., Nishitoh H., Yang X., Ichijo H. and Baltimore D. (1998) Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein daxx. Science 281: 1860-1863
131. 131 Akiba H., Nakano H., Nishinaka S., Shindo M., Kobata T., Atsuta M. et al. (1998) CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J. Biol. Chem. 273: 13353-13358
132. 132 Kanakaraj P., Schafer P. H., Cavender D. E., Wu Y., Ngo K., Grealish P. F. et al. (1998) Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 187: 2073-2079
133. 133 Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J. L. et al. (1998) MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273: 12203-12209
134. 134 Muzio M., Natoli G., Saccani S., Levrero M. and Mantovani A. (1998) The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187: 2097-2101
135. 135 Heasley L. E., Storey B., Fanger G. R., Butterfield L., Zamarripa J., Blumberg D. et al. (1996) GTPase-deficient G alpha 16 and G alpha q induce PC12 cell differentiation and persistent activation of cJun NH2-terminal kinases. Mol. Cell Biol. 16: 648-656
136. 136 Prasad M. V., Dermott J. M., Heasley L. E., Johnson G. L. and Dhanasekaran N. (1995) Activation of Jun kinase/stress-activated protein kinase by GTPase-deficient mutants of G alpha 12 and G alpha 13. J. Biol. Chem. 270: 18655-18659
137. 137 Collins L. R., Minden A., Karin M. and Brown J. H. (1996) Galpha12 stimulates c-Jun NH2-terminal kinase through the small G proteins Ras and Rac. J. Biol. Chem. 271: 17349-17353
138. 138 Voyno-Yasenetskaya T. A., Faure M. P., Ahn N. G. and Bourne H. R. (1996) Galpha12 and Galpha13 regulate extracellular signal-regulated kinase and c-Jun kinase pathways by different mechanisms in COS-7 cells. J. Biol. Chem. 271: 21081-21087
139. 139 Mitsui H., Takuwa N., Kurokawa K., Exton J. H. and Takuwa Y. (1997) Dependence of activated Galpha12-induced G1 to S phase cell cycle progression on both Ras/mitogen-activated protein kinase and Ras/Rac1/Jun N-terminal kinase cascades in NIH3T3 fibroblasts. J. Biol. Chem. 272: 4904-4910
140. 140 Tolkacheva T., Feuer B., Lorenzi M. V., Saez R. and Chan A. M. (1997) Cooperative transformation of NIH3T3 tells by G alpha12 and Rac1. Oncogene 15: 727-735
141. 141 Higashita R., Li L., Van Putten V., Yamamura Y., Zarinetchi F., Heasley L. et al. (1997) Galpha16 mimics vasoconstrictor action to induce smooth muscle alpha-actin in vascular smooth muscle cells through a Jun-NH2-terminal kinase-dependent pathway. J. Biol. Chem. 272: 25845-25850
142. 142 Coso O. A., Teramoto H., Simonds W. F. and Gutkind J. S. (1996) Signaling from G protein-coupled receptors to c-Jun kinase involves beta gamma subunits of heterotrimeric G proteins acting on a Ras and Rac1-dependent pathway. J. Biol. Chem. 271: 3963-3966
143. 143 Yamauchi J., Kaziro Y. and Itoh H. (1997) C-terminal mutation of G protein beta subunit affects differentially extracellular signal-regulated kinase and c-Jun N-terminal kinase pathways in human embryonal kidney 293 cells. J. Biol. Chem. 272: 7602-7607
144. 144 Klotz L. O., Briviba K. and Sies H. (1997) Singlet oxygen mediates the activation of JNK by UVA radiation in human skin fibroblasts. FEBS Lett. 408: 289-291
145. 145 Assefa Z., Garmyn M., Bouillon R., Merlevede W., Vandenheede J. R. and Agostinis P. (1997) Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J. Invest. Dermatol. 108: 886-891
146. 146 Adler V., Fuchs S. Y., Kim J., Kraft A., King M. P., Pelling J. et al. (1995) jun-NH2-terminal kinase activation mediated by UV-induced DNA lesions in melanoma and fibroblast cells. Cell. Growth Differ. 6: 1437-1446
147. 147 Iordanov M. S., Pribnow D., Magun J. L., Dinh T. H., Pearson J. A. and Magun B. E. (1998) Ultraviolet radiation triggers the ribotoxic stress response in mammalian cells. J. Biol. Chem. 273: 15794-157803
148. 148 Rosette C. and Karin M. (1996) Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274: 1194-1197
149. 149 Tokiwa G., Dikie I., Lev S. and Schlessinger J. (1996) Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science 273: 792-794
150. 150 Enslen H., Tokumitsu H., Stork P. J., Davis R. J. and Soderling T. R. (1996) Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade. Proc. Natl. Acad. Sci. USA 93: 10803-10808
151. 151 Yu H., Li X., Marchetto G. S., Dy R., Hunter D., Calvo B. et al. (1996) Activation of a novel calcium-dependent protein-lyrosine kinase. Correlation with c-Jun N-terminal kinase but not mitogen-activated protein kinase activation. J. Biol. Chem. 271: 29993-29998
152. 152 Li X., Yu H., Graves L. M. and Earp H. S. (1997) Protein kinase C and protein kinase A inhibit calcium-dependent but not stress-dependent c-Jun N-terminal kinase activation in rat liver epithelial cells. J. Biol. Chem. 272: 14996-15002
153. 153 Tao J., Sanghera J. S., Pelech S. L., Wong G. and Levy J. G. (1996) Stimulation of stress-activated protein kinase and p38 HOGI kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative. J. Biol. Chem. 271: 27107-27115
154. 154 Lander H. M., Jacovina A. T., Davis R. J. and Tauras J. M. (1996) Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271: 19705-19709
155. 155 Kim H., Shim J., Han P. L. and Choi E. J. (1997) Nitric oxide modulates the c-Jun N-terminal kinase/stress-activated protein kinase activity through activating c-Jun N-terminal kinase kinase. Biochemistry 36: 13677-13681
156. 156 Lo Y. Y. C., Wong J. M. S. and Cruz T. F. (1996) Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J. Biol. Chem. 271: 15703-15707
157. 157 Liu Y., Guyton K. Z., Gorospe M., Xu Q., Lee J. C. and Holbrook N. J. (1996) Differential activation of ERK, JNK/ SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite. Free Radic. Biol. Med. 21: 771-781
158. 158 Shrode L. D., Rubie E. A., Woodgett J. R. and Grinstein S. (1997) Cytosolic alkalinization increases stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) activity and p38 mitogen-activated protein kinase activity by a calcium-independent mechanism. J. Biol. Chem. 272: 13653-13659
159. 159 Zanke B. W., Boudreau K., Rubie E., Winnett E., Tibbles L. A., Zon L. et al. (1996) The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr. Biol. 6: 606-613
160. 160 Osborn M. T. and Chambers T. C. (1996) Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. J. Biol. Chem. 271: 30950-30955
161. 161 Kharbanda S., Pandey P., Ren R., Mayer B., Zon L. and Kufe D. (1995) c-Abl activation regulates induction of the SEK1/stress-activated protein kinase pathway in the cellular response to 1-beta-D-arabinofuranosylcytosine. J. Biol. Chem. 270: 30278-30281
162. 162 Kharbanda S., Ren R., Pandey P., Shafman T. D., Feller S. M., Weichselbaum R. R. et al. (1995) Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376: 785-788
163. 163 Liu Z., G., Baskaran R., Lea-Chou E. T., Wood L. D., Chen Y., Karin M. et al. (1996) Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384: 273-276
164. 164 Wilhelm D., Bender K., Knebel A. and Angel P. (1997) The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol. Cell Biol. 17: 4792-4800
165. 165 Wang T. H., Wang H. S., Ichijo H., Giannakakou P., Foster J. S., Fojo T. et al. (1998) Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273: 4928-4936
166. 166 Hazzalin C. A., Le Panse R., Cano E. and Mahadevan L. C. (1998) Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction. Mol. Cell Biol. 18: 1844-1854
167. 167 Iordanov M. S., Pribnow D., Magun J. L., Dinh T. H., Pearson J. A., Chen S. L. et al. (1997) Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol. Cell Biol. 17: 3373-3381
168. 168 Iordanov M. S. and Magun B. E. (1998) Loss of cellular K + mimics ribotoxic stress. Inhibition of protein synthesis and activation of the stress kinases SEK1/MKK4, stress-activated protein kinase/c-Jun NH2-terminal kinase 1 and p3R,HOG1 by palytoxin. J. Biol. Chem. 273: 3528-3534
169. 169 Chu Y., Solski P. A., Khosravi-Far R., Der C. J. and Kelly K. (1996) The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271: 6497-6501
170. 170 Hirsch D. D. and Stork P. J. (1997) Mitogen-activated protein kinase phosphatases inactivate stress-activated protein kinase pathways in vivo. J. Biol. Chem. 272: 4568-4575
171. 171 Scimeca J. C., Servant M. J., Dyer J. O. and Meloche S. (1997) Essential role of calcium in the regulation of MAP kinase phosphatase-1 expression, Oncogene 15: 717-725
172. 172 Franklin C. C. and Kraft A. S. (1997) Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 272: 16917-16923
173. 173 Bokemeyer D., Sorokin A., Yan M., Ahn N. G., Templeton D. J. and Dunn M. J. (1996) Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts. J. Biol. Chem. 271: 639-642
174. 174 Schliess F., Heinrich S. and Haussinger D. (1998) Hyperosmotic induction of the mitogen-activated protein kinase phosphatase MKP-1 in H4IIE rat hepatoma cells. Arch. Biochem. Biophys. 351: 35-40
175. 175 Groom L. A., Sneddon A. A., Alessi D. R., Dowd S. and Keyse S. M. (1996) Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J. 15: 3621-3632
176. 176 Muda M., Boschert U., Smith A., Antonsson B., Gillieron C., Chabert C. et al. (1997) Molecular cloning and functional characterization of a novel mitogen-activated protein kinase phosphatase, MKP-4. J. Biol. Chem. 272: 5141-5151
177. 177 Camps M., Nichols A., Gillieron C., Antonsson B., Muda M., Chabert C. et al. (1998) Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280: 1262-1265
178. 178 Muda M., Theodosiou A., Rodrigues N., Boschert U., Camps M., Gillieron C. et al. (1996) The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J. Biol. Chem. 271: 27205-27208
179. 179 Shi Z. Q., Lu W. and Feng G. S. (1998) The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases. J. Biol. Chem. 273: 4904-4908
180. 180 Dickens M., Rogers J. S., Cavanagh J., Raitano A., Xia Z., Halpern J. R. et al. (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277: 693-696
181. 181 Shim J., Lee H., Park J., Kim H. and Choi E. J. (1996) A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381: 804-806
182. 182 Patel R., Bartosch B. and Blank J. L. (1998) p21WAF1 is dynamically associated with JNK in human T-lymphocytes during cell cycle progression. J. Cell Sci. 111: 2247-2255
183. 183 Carlles C., Gonzalez-Sancho J. M. and Munoz A. (1997) Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11: 3351-3364
184. 184 Lee H. Y., Walsh G. L., Dawson M. I., Hong W. K. and Kurie J. M. (1998) All-trans-retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways. J. Biol. Chem. 273: 7066-7071
185. 185 Eyers P. A., Craxton M., Morriee N., Cohen P. and Goedert M. (1998) Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single aminoacid substitution. Chem. Biol. 5: 321-328
186. 186 Gum R. J., McLaughlin M. M., Kumar S., Wang Z., Bower M. J., Lee J. C. et al. (1998) Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J. Biol. Chem. 273: 15605-15610
187. 187 Clerk A. and Sugden P. H. (1998) The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett. 426: 93-96
188. 188 Xia Z., Dickens M., Raingeaud J., Davis R. J. and Greenberg M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331
189. 189 Park D. S., Stefanis L., Yan C. Y. I., Farinelli S. E. and Greene L. A. (1996) Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells. J. Biol. Chem. 271: 21898-21905
190. 190 Eilers A., Whitfield J., Babij C., Rubin L. L. and Ham J. (1998) Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J. Neurosci. 18: 1713-1724
191. 191 Maroney A. C., Glicksman M. A., Basma A. N., Walton K. M., Knight E. Jr., Murphy C. A. et al. (1998) Motoneuron apoptosis is blocked by CFP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J. Neurosci. 18: 104-111
192. 192 Herdegen T., Claret F. X., Kallunki T., Martin-Villalba A., Winter C., Hunter T. et al. (1998) Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J. Neurosci. 18: 5124-5135
193. 193 Kenney A. M. and Kocsis J. D. (1998) Peripheral axotomy induces long-term c-Jun ammo-terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia in vivo. J. Neurosci. 18: 1318-1328
194. 194 Yang D. D., Kuan C. Y., Whitmarsh A. J., Rincon M., Zheng T. S., Davis R. J. et al. (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389: 865-870
195. 195 Kawasaki H., Morooka T., Shimohama S., Kimura J., Hirano T., Gotoh Y. et al. (1997) Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272: 18518-18521
196. 196 Heidenreich K. A. and Kummer J. L. (1996) Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J. Biol. Chem. 271: 9891-9894
197. 197 Goillot E., Raingeaud J., Ranger A., Tepper R. I., Davis R. J., Harlow E. et al. (1997) Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci. USA 94: 3302-3307
198. 198 Lenczowski J. M., Dominguez L., Eder A. M., King L. B., Zacharchuk C. M. and Ashwell J. D. (1997) Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell Biol. 17: 170-181
199. 199 Cahill M. A., Peter M. E., Kischkel F. C., Chinnaiyan A. M., Dixit V. M., Krammer P. H. et al. (1996) CD95 (APO-1/ Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene 13: 2087-2096
200. 200 Toyoshima F., Moriguchi T. and Nishida E. (1997) Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J. Cell. Biol. 139: 1005-1015
201. 201 Juo P., Kuo C. J., Reynolds S. E., Konz R. F., Raingeaud J., Davis R. J. et al. (1997) Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol. Cell Biol. 17: 24-35
202. 202 Wajant M., Johannes F. J., Haas E., Siemienski K., Schwenzer R., Schubert G. et al. (1998) Dominant-negative FADD inhibits TNFR60-, Fas/Apol-and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr. Biol. 8: 113-116
203. 203 Yeh W. C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A. et al. (1997) Early lethality, functional NF-kappaB activation and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715-725
204. 204 Coroneos E., Wang Y., Panuska J. R., Templeton D. J. and Kester M. (1996) Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem. J. 316: 13-17
205. 205 Westwick J. K., Bielawska A. E., Dbaibo G., Hannun Y. A. and Brenner D. A. (1995) Ceramide activates the stress-activated protein kinases. J. Biol. Chem. 270: 22689-22692
206. 206 Jarvis W. D., Fornari F. A. Jr., Auer K. L., Freemerman A. J., Szabo E., Birrer M. J. et al. (1997) Coordinate regulation of stress-and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol. Pharmacol. 52: 935-947
207. 207 Brenner B., Koppenhoefer U., Weinstock C., Linderkamp O., Lang F. and Gulbins E. (1997) Fas-or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J. Biol. Chem. 272: 22173-22181
208. 208 Smith A., Ramos-Morales F., Ashworth A. and Collins M. (1997) A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells. Curr. Biol. 7: 893-906
209. 209 Adam D., Ruff A., Strelow A., Wiegmann K. and Kranke M. (1998) Induction of stress-activated protein kinases/c-Jun N-terminal kinases by the p55 tumour necrosis factor receptor does not require sphingomyelinases. Biochem. J. 333: 343-350
210. 210 Pyne S., Chapman J., Steele L. and Pyne N. J. (1996) Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle. Eur. J. Biochem. 237: 819-826
211. 211 Cuvillier O., Pirianov G., Kleuser B., Vanek P. G., Coso O. A., Gutkind S. et al. (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381: 800-803
212. 212 Spiegel S., Cuvillier O., Edsall L., Kohama T., Menzeleev R., Olivera A. et al. (1998) Roles of sphingosine-1-phosphate in cell growth, differentiation and death. Biochemistry (Mose) 63: 69-73
213. 213 Gardner A. M. and Johnson G. L. (1996) Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J. Biol. Chem. 271: 14560-14566
214. 214 Slowik M. R., De Luca L. G., Min W. and Pober J. S. (1996) Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells. Circ. Res. 79: 736-747
215. 215 Modur V., Zimmerman G. A., Prescott S. M. and McIntyre T. M. (1996) Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J. Biol. Chem. 271: 13094-13102
216. 216 Roulston A., Reinhard C., Amiri P. and Williams L. T. (1998) Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J. Biol. Chem. 273: 10232-10239
217. 217 Johnson N. L., Gardner A. M., Diener K. M., Lange-Carter C. A., Gleavy J., Jarpe M. B. et al. (1996) Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J. Biol. Chem. 271: 3229-3237
218. 218 Chuang T. H., Hahn K. M., Lee J. D., Danley D. E. and Bokoch G. M. (1997) The small GTPase Cdc42 initiates an apoptotic signaling pathway in Jurkat T lymphocytes. Mol. Biol. Cell. 8: 1687-1698
219. 219 Gabai V. L., Meriin A. B., Mosser D. D., Caron A. W., Rits S., Shifrin V. I. et al. (1997) Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J. Biol. Chem. 272: 18033-18037
220. 220 Mosser D. D., Caron A. W., Bourget L., Denis-Larose C. and Massie B. (1997) Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol. Cell Biol. 17: 5317-5327
221. 221 Franklin C. C., Srikanth S. and Kraft A. S. (1998) Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis. Proc. Natl. Acad. Sci. USA 95: 3014-3019
222. 222 Gajate C., Santos-Beneit A., Modolell M. and Mollinedo F. (1998) Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecy1-2-O-methyl-rac-glycero-3-phosphocholine. Mol. Pharmacol. 53: 602-612
223. 223 Seimiya H., Mashima T., Toho M. and Tsuruo T. (1997) c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J. Biol. Chem. 272: 4631-4636
224. 224 Potapova O., Haghighi A., Bost F., Liu C., Birrer M. J., Gjerset R. et al. (1997) The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272: 14041-14044
225. 225 Kasibhatla S., Brunner T., Genestier L., Echeverri F., Mahboubi A. and Green D. R. (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol. Cell 1: 543-551
226. 226 Faris M., Kokot N., Latinis K., Kasibhatla S., Green D. R., Koretzky G. A. et al. (1998) The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J. Immunol. 160: 134-144
227. 227 Wang X., Martindale J. L., Liu Y. and Holbrook N. J. (1998) The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 333: 291-300
228. 228 Stadheim T. A. and Kucera G. L. (1998) Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis. Biochem. Biophys. Res. Commun. 245: 266-271
229. 229 Chauhan D., Pandey P., Ogata A., Teoh G., Treon S., Urashima M. et al. (1997) Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism. Oncogene 15: 837-843
230. 230 Ishizuka T., Sakata N., Johnson G. L., Gelfand E. W. and Terada N. (1997) Rapamyein potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells. Biochem. Biophys. Res. Commun. 230: 386-391
231. 231 Frisch S. M., Vuori K., Kelaita D. and Sicks S. (1996) A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA. J. Cell. Biol. 135: 1377-1382
232. 232 Khwaja A. and Downward J. (1997) Lack of correlation between activation of Jun-NH2-terminal kinase and induction of apoptosis after detachment of epithelial cells. J. Cell. Biol. 139: 1017-1023
233. 233 Clark G. J., Westwick J. K. and Der C. J. (1997) p120 GAP modulates Ras activation of Jun kinases and transformation. J. Biol. Chem. 272: 1677-1681
234. 234 Cortez D., Reuther G. and Pendergast A. M. (1997) The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells. Oncogene 15: 2333-2342
235. 235 Raitano A. B., Halpern J. R., Hambuch T. M. and Sawyers C. L. (1995) The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc. Natl. Acad. Sci. USA 92: 11746-11750
236. 236 Rodrigues G. A., Park M. and Schlessinger J. (1997) Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J. 16: 2634-2645
237. 237 O'Hagan R. C. and Hassell J. A. (1998) The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase. Oncogene 16: 301-310
238. 238 Bost F., McKay R., Dean N. and Mercola D. (1997) The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem. 272: 33422-33429
239. 239 Antonyak M. A., Moscatello D. K. and Wong A. J. (1998) Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor. J. Biol. Chem. 273: 2817-2822
240. 240 Zohn I. E., Symons M., Chrzanowska-Wodnicka M., Westwick J. K. and Der C. J. (1998) Mas oncogene signaling and transformation require the small GTP-binding protein Rac. Mol. Cell Biol. 18: 1225-1235
241. 241 Chiariello M., Visconti R., Carlomagno F., Melillo R. M., Bucci C., de Franciscis V. et al. (1998) Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKS and JNKs pathways induced by Ret. Oncogene 16: 2435-2445
242. 242 Xu X., Heidenreich O., Kitajima I., McGuire K., Li Q., Su B. et al. (1996) Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oneogene 13: 135-142
243. 243 Liu Z. Y., Ganju R. K., Wang J. F., Ona M. A., Hatch W. C., Zheng T. et al. (1997) Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. J. Clin. Invest. 99: 1798-17804
244. 244 Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E. G., Gutkind J. S. et al. (1998) G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391: 86-89
245. 245 Watanabe G., Howe A., Lee R. J., Albanese C., Shu I. W., Karnezis A.N. et al. (1996) Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA 93: 12861-12866
246. 246 Molnar A., Theodoras A. M., Zon L. I. and Kyriakis J. M. (1997) Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J. Biol. Chem. 272: 13229-13235
247. 247 Takenaka K., Moriguchi T. and Nishida E. (1998) Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 280: 599-602
248. 248 Kilbey A., Black E. J., Unlu M. and Gillespie D. A. (1996) The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction. Oncogene 12: 2409-2418
249. 249 May G. H., Funk M., Black E. J., Clark W., Hussain S., Woodgett J. R. et al. (1998) An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo. Curr. Biol. 8: 117-120
250. 250 Sluss H. K., Han Z., Barrett T., Davis R. J. and Ip Y. T. (1996) A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes Dev 10: 2745-2758
251. 251 Glise B., Bourbon H. and Noselli S. (1995) hemipterous encodes a novel Drosophila MAP kinase kinase, required for epithelial cell sheet movement. Cell 83: 451-461
252. 252 Riesgo-Escovar J. R. and Hafen E. (1997) Drosophila Jun kinase regulates expression of decapentaplegic via the ETS-domain protein Aop and the AP-1 transcription factor DJun during dorsal closure. Genes Dev 11: 1717-1727
253. 253 Hou X. S., Goldstein E. S. and Perrimon N. (1997) Drosophila Jun relays the Jun amino-terminal kinase signal transduction pathway to the Decapentaplegic signal transduclion pathway in regulating epithelial cell sheet movement. Genes Dev 11: 1728-1737
254. 254 Glise B. and Noselli S. (1997) Coupling of Jun amino-terminal kinase and Decapentaplegic signaling pathways in Drosophila morphogenesis. Genes Dev. 11: 1738-1747
255. 255 Riesgo-Escovar J. R. and Hafen E. (1997) Common and distinct roles of DFos and DJun during Drosophila development. Science 278: 669-672
256. 256 Sluss H. K. and Davis R. J. (1997) Embryonic morphogenesis signaling pathway mediated by JNK targets the transcription factor JUN and the TGF-beta homologue decapentaplegic. J. Cell. Biochem. 67: 1-12
257. 257 Martin-Blanco E. (1998) Regulatory control of signal transduction during morphogenesis in Drosophila. Int. J. Dev. Biol. 42: 363-368
258. 258 Riesgo-Escovar J. R., Jenni M., Fritz A. and Hafen E. (1996) The Drosophila Jun-N-terminal kinase is required for cell morphogenesis but not for DJun-dependent cell fate specification in the eye. Genes Dev. 10: 2759-2768
259. 259 Kockel L., Zeitlinger J., Staszewski L. M., Mlodzik M. and Bohmann D. (1997) Jun in Drosophila development: redundant and nonredundant functions and regulation by two MAPK signal transduction pathways. Genes Dev. 11: 1748-1758
260. 260 Luo L., Lee T., Tsai L., Tang G., Jan L. Y. and Jan Y. N. (1997) Genghis Khan (Gek) as a putative effector for Drosophila Cdc42 and regulator of actin polymerization. Proc. Natl. Acad. Sci. USA 94: 12963-12968
261. 261 Boutros M., Paricio N., Strutt D. I. and Mlodzik M. (1998) Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling. Cell 94: 109-118
262. 262 Strutt D. I., Weber U. and Mlodzik M. (1997) The role of RhoA in tissue polarity and Frizzled signalling. Nature 387: 292-295
263. 263 Swat W., Fujikawa K., Ganiatsas S., Yang D., Xavier R. J., Harris N. L. et al. (1998) SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Immunity 8: 625-634
264. 264 Su B., Jacinto E., Hibi M., Kallunki T., Karin M. and Ben-Neriah Y. (1994) JNK is involved in signal integration during costimulalion of T lymphocytes. Cell 77: 727-736
265. 265 Faris M., Kokot N., Lee L. and Nel A. E. (1996) Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in jurkat T cells. Evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation. J. Biol. Chem. 271: 27366-27373
266. 266 Hoffmeyer A., Avots A., Flory E., Weber C. K., Serfling E. and Rapp U. R. (1998) The GABP-responsive element of the interleukin-2 enhancer is regulated by JNK/SAPK-activating pathways in T lymphocytes. J. Biol. Chem. 273: 10112-10119
267. 267 Chen C. Y., Del Gatto-Konczak F., Wu Z. and Karin M. (1998) Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280: 1945-1949
268. 268 Nishina H., Bachmann M., Oliveira-dos-Santos A. J., Kozieradzki I., Fischer K. D., Odermatt B. et al. (1997) Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J. Exp. Med. 186: 941-953
269. 269 Matsuda S., Moriguchi T., Koyasu S. and Nishida F. (1998) T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 273: 12378-12382
270. 270 Jacinto E., Werlen G. and Karin M. (1998) Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes. Immunity 8: 31-41
271. 271 Werlen G., Jacinto E., Xia Y. and Karin M. (1998) Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17: 3101-3111
272. 272 DeSilva D. R., Jones E. A., Feeser W. S., Manos E. J. and Scherle P. A. (1997) The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells. Cell. Immunol. 180: 116-123
273. 273 Crawley J. B., Rawlinson L., Lali F. V., Page T. H., Saklatvala J. and Foxwell B. M. (1997) T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J. Biol. Chem. 272: 15023-15027
274. 274 Issazadeh S., Navikas V., Schaub M., Sayegh M. and Khoury S. (1998) Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161: 1104-1112
275. 275 Lin H., Rathmell J. C., Gray G. S., Thompson C. B., Leiden J. M. and Alegre M. L. (1998) Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J. Exp. Med. 188: 199-204
276. 276 Saito K., Sakurai J., Ohata J., Kohsaka T., Hashimoto H., Okumura K. et al. (1998) Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28. J. Immunol. 160: 4225-4231
277. 277 Calvo C. R., Amsen D. and Kruisbeek A. M. (1997) Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J. Exp. Med. 186: 1645-1653
278. 278 Li W., Whaley C. D., Mondino A. and Mueller D. L. (1996) Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science 271: 1272-1276
279. 279 DeSilva D. R., Feeser W. S., Tancula E. J. and Scherle P.A. (1996) Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways. J. Exp. Med. 183: 2017-2023
280. 280 Jabado N., Pallier A., Jauliac S., Fischer A. and Hivroz C. (1997) gp160 of HIV or anti-CD4 monoclonal antibody ligation of CD4 induces inhibition of JNK and ERK-2 activities in human peripheral CD4+ T lymphocytes. Eur. J. Immunol. 27: 397-404
281. 281 Brenner B., Koppenhoefer U., Grassme H., Kun J., Lang F. and Gulbins E. (1997) Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes. FEBS Lett. 417: 301-316
282. 282 Brenner B., Weinmann S., Grassme H., Lang F., Linderkamp O. and Gulbins E. (1997) L-selectin activates JNK via src-like tyrosine kinases and the small G-protein Rac. Immunology 92: 214-219
283. 283 Sakata N., Patel H. R., Terada N., Aruffo A., Johnson G. L. and Gelfand E. W. (1995) Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J. Biol. Chem. 270: 30823-30828
284. 284 Sutherland C. L., Heath A. W., Pelech S. L., Young P. R. and Gold M. R. (1996) Differential activation of the ERK, JNK and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 157: 3381-3390
285. 285 Berberich I., Shu G., Siebelt F., Woodgett J. R., Kyriakis J. M. and Clark E. A. (1996) Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J. 15: 92-101
286. 286 Li Y. Y., Baccam M., Waters S. B., Pessin J. E., Bishop G. A. and Koretzky G. A. (1996) CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J. Immunol. 157: 1440-1447
287. 287 Kilger E., Kieser A., Baumann M. and Hammerschmidt W. (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17: 1700-1709
288. 288 Han Z. S., Enslen H., Hu X., Meng X., Wu I. H., Barrett T. et al. (1998) A conserved p38 mitogen-activated protein kinase pathway regulates Drosophila immunity gene expression. Mol. Cell Biol. 18: 3527-3539
289. 289 Hambleton J., Weinstein S. L., Lem L. and DeFranco A. L. (1996) Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. USA 93: 2774-2778
290. 290 Sanghera J. S., Weinstein S. L., Aluwalia M., Girn J. and Pelech S. L. (1996) Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J. Immunol. 156: 4457-4465
291. 291 Swantek J. L., Cobb M. H. and Geppert T. D. (1997) Jun N-terminal kinase/stress-activated protein kinase (JNK/ SAPK) is required lor lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/ SAPK. Mol. Cell Biol. 17: 6274-6282
292. 292 Hardt W. D., Chen L. M., Schuebel K. E., Bustelo X. R. and Galan J. E. (1998) S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93: 815-826
293. 293 Chen L. M., Hobbie S. and Galan J. E. (1996) Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses. Science 274: 2115-2118
294. 294 Hobbie S., Chen L. M., Davis R. J. and Galan J. E. (1997) Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J. Immunol. 159: 5550-5559
295. 295 Ruckdeschel K., Machold J., Roggenkamp A., Schubert S., Pierre J., Zumbihl R. et al. (1997) Yersinia enterocolitica promotes deactivalion of macrophage mitogen-activated protein kinases extracellular signal-regulated kinase-1/2. p38, and c-Jun NH2-terminal kinase. Correlation with its inhibitory effect on tumor necrosis factor-alpha production. J. Biol. Chem. 272: 15920-15927
296. 296 Palmer L. E., Hobbie S., Galan J. E. and Bliska J. B. (1998) YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol. Microbiol. 27: 953-965
297. 297 Rose D. M., Winston B. W., Chan E. D., Riches D. W., Gerwins P., Johnson G. L. et al. (1997) Fc gamma receptor cross-linking activates p42, p38 and JNK/SAPK mitogen-actlivated protein kinases in murine macrophages: role for p42MAPK in Fc gamma receptor-stimulated TNF-alpha synthesis. J. Immunol. 158: 3433-3438
298. 298 Chan E. D., Winston B. W., Jarpe M. B., Wynes M. W. and Riches D. W. (1997) Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNF alpha. Proc. Natl. Acad. Sci. USA 94: 13169-131174
299. 299 Winston B. W., Chan E. D., Johnson G. L. and Riches D. W. (1997) Activation of p38mapk, MKK3, and MKK4 by TNF-alpha in mouse bone marrow-derived macrophages. J. Immunol. 159: 4491-4497
300. 300 Ganju R. K., Dutt P., Wu L., Newman W., Avraham H., Avraham S. et al. (1998) Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. Blood 91: 791-797
301. 301 Hata D., Kitaura J., Hartman S. E., Kawakami Y., Yokota T. and Kawakami T. (1998) Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells. Dependence on the c-Jun N-terminal kinase activation pathway. J. Biol. Chem. 273: 10979-10987
302. 302 Ishizuka T., Oshiba A., Sakata N., Terada N., Johnson G. L. and Gelfand E. W. (1996) Aggregation of the FcepsilonR1 on mast cells stimulates c-Jun amino-terminal kinase activity. A response inhibited by wortmannin. J. Biol. Chem. 271: 12762-12766
303. 303 Ishizuka T., Terada N., Gerwins P., Hamelmann E., Oshiba A., Fanger G. R. et al. (1997) Mast cell tumor necrosis factor alpha production is regulated by MEK kinases. Proc. Natl. Acad. Sci. USA 94: 6358-6363
304. 304 El Benna J., Han J., Park J. W., Schmid E., Ulevitch R. J. and Babior B. M. (1996) Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK. Arch. Biochem. Biophys. 334: 395-400
305. 305 Rane M. J., Carrithers S. L., Arthur J. M., Klein J. B. and McLeish K. R. (1997) Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: role in activation of reduced nicotinamide adenine dinucleotide oxidase. J. Immunol. 159: 5070-5078
306. 306 Tournier C., Thomas G., Pierre J., Jacquemin C., Pierre M. and Saunier B. (1997) Mediation by arachidonic acid metabolites of the H2O2-induced stimulation of mitogen-activated protein kinases (extracellular-signal-regulated kinase and c-Jun NH2-terminal kinase). Eur. J. Biochem. 244: 587-595
307. 307 Rizzo M. T. and Carlo-Stella C. (1996) Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino-terminal kinases in stromal cells. Blood 88: 3792-3800
308. 308 Bleich D., Chen S., Wen Y. and Nadler J. L. (1997) The stress-activated c-Jun protein kinase (JNK) is stimulated by lipoxygenase pathway product 12-HETE in RIN m5F cells. Biochem. Biophys. Res. Commun. 230: 448-451
309. 309 See R. H. and Shi Y. (1998) Adenovirus EIB 19,000-molecular-weight protein activates c-Jun N-terminal kinase and c-Jun-mediated transcription. Mol. Cell Biol. 18: 4012-4022
310. 310 Kieser A., Kilger E., Gires O., Ueffing M., Kolch W. and Hammerschmidt W. (1997) Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16: 6478-6485
311. 311 Eliopoulos A. G. and Young L. S. (1998) Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16: 1731-1742
312. 312 Benn J., Su F., Doria M. and Schneider R. J. (1996) Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J. Virol. 70: 4978-4985
313. 313 Kumar A., Manna S. K., Dhawan S. and Aggarwal B. B. (1998) HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J. Immunol. 161: 776-781
314. 314 Li C. J., Ueda Y., Shi B., Borodyansky L., Huang L., Li Y. Z. et al. (1997) Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proc. Natl. Acad. Sci. USA 94: 8116-8120
315. 315 Ganju R. K., Munshi N., Nair B. C., Liu Z. Y., Gill P. and Groopman J. E. (1998) Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J. Virol. 72: 6131-6137
316. 316 Kumar S., Orsini M. J., Lee J. C., McDonnell P. C., Debouck C. and Young P. R. (1996) Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase. J. Biol. Chem. 271: 30864-30869
317. 317 Galley Y., Hagens G., Glaser I., Davis W., Eichhorn M. and Dobbelaere D. (1997) Jun NH2-terminal kinase is constitutively activated in T cells transformed by the intracellular parasite Theileria parva. Proc. Natl. Acad. Sci. USA 94: 5119-5124
318. 318 Botteron C. and Dobbelaere D. (1998) AP-1 and ATF-2 are constitutively activated via the JNK pathway in Theileria parva-transformed T-cells. Biochem. Biophys. Res. Commun. 246: 418-421
319. 319 Da Silva J., Pierrat B., Mary J. L. and Lesslauer W. (1997) Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272: 28373-28380
320. 320 Reunanen N., Westermarck J., Hakkinen L., Holmstrom T. H., Elo I., Eriksson J. E. et al. (1998) Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J. Biol. Chem. 273: 5137-5145
321. 321 Gum R., Wang H., Lengyel E., Juarez J. and Boyd D. (1997) Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase-and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14: 1481-1493
322. 322 Poulos J. E., Weber J. D., Bellezzo J. M., Di Bisceglie A. M., Britton R. S., Bacon B. R. et al. (1997) Fibronectin and cytokines increase JNK, ERK, AP-1 activity and transin gene expression in rat hepatic stellate cells. Am. J. Physiol. 273: G804-811
323. 323 Fisher G. J., Talwar H. S., Lin J., Lin P., McPhillips F., Wang Z. et al. (1998) Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J. Clin. Invest. 101: 1432-1440
324. 324 Silberman S., Janulis M. and Schultz R. M. (1997) Characterization of downstream Ras signals thut induce alternative protease-dependent invasive phenotypes. J. Biol. Chem. 272: 5927-5935
325. 325 Miralles F., Parra M., Caelles C., Nagamine Y., Felez J. and Munoz-Canoves P. (1998) UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element. Mol. Cell Biol. 18: 4537-4547
326. 326 Gum R., Juarez J., Allgayer H., Mazar A., Wang Y. and Boyd D. (1998) Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules. Oncogene 17: 213-225
327. 327 Xie W. and Herschman H. R. (1995) v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J. Biol. Chem. 270: 27622-27628
328. 328 Xie W. and Herschman H. R. (1996) Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J. Biol. Chem. 271: 31742-31748
329. 329 Newton R., Stevens D. A., Hart L. A., Lindsay M., Adcock I. M. and Barnes P. J. (1997) Superinduction of COX-2 mRNA by cycloheximide and interleukin-1beta involves increased transcription and correlates with increased NF-kappaB and JNK activation. FEBS Lett. 418: 135-138
330. 330 Guan Z., Buckman S. Y., Pentland A. P., Templeton D. J. and Morrison A. R. (1998) Induction of cyclooxygenase-2 by the activated MEKK1 →SEK1/MKK4→p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 273: 12901-12908
331. 331 Miller C., Zhang M., He Y., Zhao J., Pelletier J. P., Martel-Pelletier J. et al. (1998) Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. J. Cell Biochem. 69: 392-413
332. 332 Karmann K., Min W., Fanslow W. C. and Pober J. S. (1996) Activation and homologous desensitizalion of human endothelial cells by CD40 ligand, tumor necrosis factor and interleukin 1. J. Exp. Med. 184: 173-182
333. 333 Read M. A., Whitley M. Z., Gupta S., Pierce J. W., Best J., Davis R. J. et al. (1997) Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 272: 2753-2761
334. 334 Schmitz U., Ishida T., Ishida M., Surapisitchat J., Hasham M. I., Pelech S. et al. (1998) Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: role in activation of JNK. Circ. Res. 82: 1272-1278
335. 335 Kudoh S., Komuro I., Mizuno T., Yamazaki T., Zou Y., Shiojima I. et al. (1997) Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocyles of neonatal rats. Circ. Res. 80: 139-146
336. 336 Huwiler A., van Rossum O., Wartmann M. and Pfeilschifler J. (1998) Angiotensin II stimulation of the stress-activated protein kinases in renal mesangial cells is mediated by the angiotensin ATI receptor subtype. Eur. J. Pharmacol. 343: 297-302
337. 337 Zohn I. E., Yu H., Li X., Cox A. D. and Earp H. S. (1995) Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase. Mol. Cell Biol. 15: 6160-6168
338. 338 Hu Y., Cheng L., Hochleitner B. W. and Xu Q. (1997) Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 17: 2808-2816
339. 339 Kim S., Izumi Y., Yano M., Hamaguchi A., Miura K., Yamanaka S. et al. (1998) Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. Circulation 97: 1731-1737
340. 340 Li Y. S., Shyy J. Y., Li S., Lee J., Su B., Karin M. et al. (1996) The Ras-JNK pathway is involved in shear-induced gene expression. Mol. Cell Biol. 16: 5947-5954
341. 341 Jo H., Sipos K., Go Y. M., Law R., Rong J. and McDonald J. M. (1997) Differential effect of shear stress on extracellular signal-regulated kinase and N-terminal Jun kinase in endothelial cells. Gi2-and Gbeta/gamma-dependent signaling pathways. J. Biol. Chem. 272: 1395-1401
342. 342 Rousseau S., Houle F., Landry J. and Huot J. (1997) p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15: 2169-2177
343. 343 Lin Z. Y., Ganju R. K., Wang J. F., Schweitzer K., Weksler B., Avraham S. et al. (1997) Characterization of signal transduction pathways in human bone marrow endothelial cells. Blood 90: 2253-2259
344. 344 Ramirez M. T., Sah V. P., Zhao X. L., Hunter J. J., Chien K. R. and Brown J. H. (1997) The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J. Biol. Chem. 272: 14057-14061
345. 345 Thorburn J., Xu S. and Thorburn A. (1997) MAP kinase-and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J. 16: 1888-1900
346. 346 Bogoyevitch M. A., Gillespie-Brown J., Ketterman A. J., Fuller S. J., Ben-Levy R., Ashworth A. et al. (1996) Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart . p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ. Res. 79: 162-173
347. 347 Wang Y., Su B., Sah V. P., Brown J. H., Han J. and Chien K. R. (1998) Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J. Biol. Chem. 273: 5423-5426
348. 348 Zechner D., Thuerauf D. J., Hanford D. S., McDonough P. M. and Glembotski C. C. (1997) A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization and cardiac-specific gene expression. J. Cell. Biol. 139: 115-127
349. 349 Liang F., Wu J., Garami M. and Gardner D. G. (1997) Mechanical strain increases expression of the brain natriuretic peptide gene in rat cardiac myocytes. J. Biol. Chem. 272: 28050-28056
350. 350 Reusch H. P., Chan G., Ives H. E. and Nemenoff R. A. (1997) Activation of JNK/SAPK and ERK by mechanical strain in vascular smooth muscle cells depends on extracellular matrix composition. Biochem. Biophys. Res. Commun. 237: 239-244
351. 351 McDonough P. M., Hanford D. S., Sprenkle A. B., Mellon N. R. and Glembotski C.C. (1997) Collaborative roles for c-Jun N-terminal kinase, c-Jun serum response factor and Sp1 in calcium-regulated myocardial gene expression. J. Biol. Chem. 272: 24046-24053
352. 352 Li W. G., Zaheer A., Coppey L. and Oskarsson H. J. (1998) Activation of JNK in the remote myocardium after large myocardial infaretion in rats. Biochem. Biophys. Res. Commun. 246: 816-820
353. 353 Bogoyevitch M. A., Ketterman A. J. and Sugden P. H. (1995) Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J. Biol. Chem. 270: 29710-29717
354. 354 Clerk A. and Sugden P. H. (1997) Cell stress-induced phosphorylation of ATF2 and c-Jun transcription factors in rat ventricular myocytes. Biochem. J. 325: 801-810
355. 355 Foltz I. N. and Schrader J. W. (1997) Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 89: 3092-3096
356. 356 Liu R., Itoh T., Arai K. and Watanabe S. (1997) Activation of c-Jun N-terminal kinase by human granulocyte macrophage-colony stimulating factor in BA/F3 cells. Biochem. Biophys. Res. Commun. 234: 611-615
357. 357 de Groot R. P., van Dijk T. B., Caldenhoven E., Coffer P. J., Raaijmakers J. A., Lammers J. W. J. et al. (1997) Activation of 12-O-tetradecanoylpnorbol-13-acetate response element-and dyad symmetry element-dependent transcription by interleukin-5 is mediated by Jun N-terminal kinase/stress-activated protein kinase kinases. J. Biol. Chem. 272: 2319-2325
358. 358 Nagata Y., Nishida E. and Todokoro K. (1997) Activation of JNK signaling pathway by erythropoietin, thrombopoietin and interleukin-3. Blood 89: 2664-2669
359. 359 Nagata Y., Moriguchi T., Nishida E. and Todokoro K. (1997) Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3. Blood 90: 929-934
360. 360 Auer K. L., Contessa J., Brenz-Verca S., Pirola L., Rusconi S., Cooper G. et al. (1998) The Ras/Rac1/Cdc42/SEK/JNK/ c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Mol. Biol. Cell 9: 561-573
361. 361 Mitsui H., Maruyama T., Kimura S. and Takuwa Y. (1998) Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells. Hepatology 27: 1362-1367
362. 362 Elbirt K. K., Whitmarsh A. J., Davis R. J. and Bonkovsky H. L. (1998) Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases. J. Biol. Chem. 273: 8922-8931
363. 363 Ainbinder E., Bergelson S. and Daniel V. (1997) Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene. Recept. Signal Transduct. 7: 279-289
364. 364 Bendinelli P., Piccoletti R., Maroni P. and Bernelli-Zazzera A. (1996) The MAP kinase cascades are activated during post-ischemic liver reperfusion. FEBS Lett. 398: 193-197
365. 365 Bradham C. A., Stachlewitz R. F., Gao W., Qian T., Jayadev S., Jenkins G. et al. (1997) Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 25: 1128-1135
366. 366 Onishi I., Tani T., Hashimoto T., Shimizu K., Yagi M., Yamamoto K. et al. (1997) Activation of c-Jun N-terminal kinase during ischemia and reperfusion in mouse liver. FEBS Lett. 420: 201-204
367. 367 Zhang Z. and Cohen D. M. (1996) NaCl but not urea activates p38 and jun kinase in mIMCD3 murine inner medullary cells. Am. J. Physiol. 271: F1234-1238
368. 368 Berl T., Siriwardana G., Ao L., Butterfield L. M. and Heasley L. E. (1997) Multiple mitogen-activated protein kinases are regulated by hyperosmolality in mouse IMCD cells. Am. J. Physiol. 272: F305-311
369. 369 Sheikh-Hamad D., Di Mari J., Suki W. N., Safirstein R., Watts B. A. r. and Rouse D. (1998) p38 kinase activity is essential for osmotic induction of mRNAs for HSP70 and transporter for organic solute betaine in Madin-Darby canine kidney cells. J. Biol. Chem. 273: 1832-1837
370. 370 Kultz D., Madhany S. and Burg M. B. (1998) Hyperosmolality causes growth arrest of murine kidney cells. Induction of GADD45 and GADD153 by osmosensing via stress-activated protein kinase 2. J. Biol. Chem. 273: 13645-13651
371. 371 Wojtaszek P. A., Heasley L. E., Siriwardana G. and Berl T. (1998) Dominant-negative c-Jun NH2-terminal kinase 2 sensitizes renal inner medullary collecting duct cells to hypertonicity-induced lethality independent of organic osmolyte transport. J. Biol. Chem. 273: 800-804
372. 372 Pombo C. M., Bonventre J. V., Avruch J., Woodgett J. R., Kyriakis J. M. and Force T. (1994) The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J. Biol. Chem. 269: 26546-26551
373. 373 DiMari J., Megyesi J., Udvarhelyi N., Price P., Davis R. and Safirstein R. (1997) N-acetyl cysteine ameliorates ischemic renal failure. Am. J. Physiol. 272: F292-298